Skip to main content
Signal8

LEUNG GABRIEL

SEC insider (Form 3/4/5 filer). CIK 0001236183. Director at NovoCure Ltd (NVCR). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in WAYNE, PA.

Companies LEUNG GABRIEL has filed insider reports for

  • NovoCure Ltd (NVCR): Director
LEUNG GABRIEL profile photo

LEUNG GABRIEL

CIK: 0001236183

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NovoCure Ltd logo
NVCR

NovoCure Ltd

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Jun 3, 2026
    Award
    Direct
    11.6K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Jun 2, 2026
    Sale
    Direct
    2.9K shares at avg. $15.77$46K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Jun 4, 2025
    Award
    Direct
    11.2K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Jun 3, 2025
    Sale
    Direct
    999 shares at avg. $17.31$17K

1-4 of 4